Answers are grounded in this paper and cite their sources.
To the Editor: Atopic dermatitis (AD) affects an estimated 7.2% of adults and 10.7% of children in the United States; however, AD might affect different races at a varying rate. 1 Compared to their European American counterparts, Asian/Pacific Islanders and African Americans are 7 and 3 times more likely, respectively, to be given a diagnosis of AD. 2 Despite being disproportionately affected by AD, minority groups might be underrepresented in clinical trials of AD treatments.3 One explanation for this imbalance might be that ethnoracial representation differs across regions in the United States, perhaps in regions where clinical trials are conducted.Price et al 3 investigated racial representation in clinical trials of AD globally and found that patients of color are consistently underrepresented.Research on racial representation in clinical trials within the United States-on national and regional scales-is lacking from the current AD literature.We
No takes yet. Share an insight, caveat, or question.
Sophia Arbuiso (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: